- Self-pay: $299 (2.5 mg), $399 (5 mg) or $449 (7.5 mg and up, refill within 45 days) a month for the KwikPen or vials.
- Retail pharmacy: the KwikPen Self-Pay Savings Card gets you the same price outside LillyDirect.
- Medicare Part D: the GLP-1 Bridge is $50 a month for the KwikPen if you are eligible.
- Covered condition: ask your prescriber about resubmitting with records for an approved use.
- Do not stop or switch medicines without talking to your prescriber.
First: check why it was denied
Plans often limit coverage to specific conditions, or approve it for a fixed period. Before paying out of pocket, ask your insurer exactly what they need. Zepbound is approved for weight management in adults with obesity, or overweight with at least one weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity.[5] If you have a condition your plan lists, your prescriber may be able to resubmit the prior authorization with the records the plan asks for.
Option 1: Lilly self-pay (LillyDirect)
Lilly lists the same monthly self-pay price for the Zepbound KwikPen and the single-dose vials:[1, 2]
| Dose | KwikPen or vials, per month |
|---|---|
| 2.5 mg | $299 |
| 5 mg | $399 |
| 7.5 mg to 15 mg | $449 if you refill within 45 days of your previous delivery |
Needles for the KwikPen, or syringes and needles for vials, are extra.[1, 2] Prices on this page come from our price checker, which we re-check every week.
Self-pay still needs a prescription. If you also need a new prescriber, see our guide togetting a prescription online and ourGoodLife Health review.
Option 2: the KwikPen savings card at a regular pharmacy
If LillyDirect's delivery does not suit you, Lilly's KwikPen Self-Pay Savings Card gives you the same self-pay prices at major pharmacies.[3] A few things to know:
- It works for the KwikPen only, not the vials or the single-dose pen. You need a prescription for the KwikPen.[3]
- Government insurance beneficiaries are excluded.[1]
- You get the card on Lilly's savings page, then give the pharmacy its numbers. That is the "coupon" a pharmacy asks for.
- Lilly does not list which pharmacies take it, so call ahead.
Option 3: the Medicare GLP-1 Bridge
If you have Medicare Part D, the Medicare GLP-1 Bridge covers the Zepbound KwikPen for $50 a month for eligible people. Eligibility depends on BMI and certain health conditions, and people with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease are excluded. Medicare must approve you before you pay.[4] The full rules are in our Zepbound savings guide.
Option 4: a different medicine your plan does cover
Plans cover different medicines for different conditions. Mounjaro, which is also tirzepatide, is approved for type 2 diabetes.[7] Wegovy's label includes reducing cardiovascular risk in some adults and, for the injection, a form of liver disease (MASH).[6] Which medicine is right for you, and whether switching makes sense, is your prescriber's decision. Our price checker lists the self-pay and savings card prices for each.
What about compounded tirzepatide?
There is no FDA-approved generic Zepbound. Compounded versions are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality.[8] If you are considering one, read ourguide to compounded GLP-1s first. What certified providers charge is in the separatecompounded section of the price checker.
Common questions
How much is Zepbound if my insurance stops covering it?
Lilly's self-pay price for the Zepbound KwikPen or vials is $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg to 15 mg, as long as you refill within 45 days of your previous delivery. Needles or syringes cost extra.
Can I get the self-pay price at a regular pharmacy?
Yes, for the KwikPen. Lilly says its KwikPen Self-Pay Savings Card gives the same self-pay prices as LillyDirect at major pharmacies. It does not apply to the vials or the single-dose pen, and government insurance is excluded.
My insurer says I need a qualifying condition. Which conditions is Zepbound approved for?
Zepbound is approved for weight management in adults with obesity, or overweight with at least one weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity. Whether your plan covers it for a given condition is up to the plan, so ask your prescriber about resubmitting the prior authorization with the right records.
What if I have Medicare?
If you have Medicare Part D, you may qualify for the Medicare GLP-1 Bridge, which covers the Zepbound KwikPen for $50 a month if you meet its eligibility rules. People with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease are excluded from the Bridge.
Is there a generic Zepbound?
No. There is no FDA-approved generic. What people call "generic" is usually compounded tirzepatide, which is not FDA-approved.
Sources
- Eli Lilly and Company. Zepbound savings and coverage options. Revised n/a (web page, programs through 12/31/2026). Last checked 2026-11-04.
- Eli Lilly and Company. Zepbound KwikPen and vials on LillyDirect. Revised n/a (web page). Last checked 2026-10-01.
- Eli Lilly and Company (media statement). Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect. Revised March 16, 2026. Last checked 2026-10-01.
- Centers for Medicare and Medicaid Services. Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month (fact sheet). Revised n/a (program began July 1, 2026). Last checked 2026-10-01.
- Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information. Revised 08/2026. Last checked 2026-10-01.
- Novo Nordisk. Wegovy (semaglutide) Prescribing Information. Revised 06/2026. Last checked 2026-10-01.
- Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. Revised 08/2026. Last checked 2026-10-01.
- US Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. Revised Content current as of 10/01/2026. Last checked 2026-10-01.